A reference post rather than a discussion. Corrections are the point; I would rather this be right than mine. It is about vendor vetting, and it is deliberately narrow — everything I am not confident about is marked as such.
What is actually established
Prices dramatically below market are the strongest single signal, and the reason is arithmetic rather than suspicion. Synthesis, testing, and cold-chain shipping have floors. A price well under the floor means something was skipped, and the two things that get skipped are testing and content.
The condition it depends on
One flattering data point from a group buy is not consistency. Consistency means separate batches, separately commissioned, over months.
The practical version
Red flags, in rough order of how much they should worry you: no verifiable address, no batch numbers, prices far under market, vendor-commissioned tests only, pressure toward irreversible payment, and shipping with no temperature control.
What I am not sure about
The narrow version of the question is how people are distinguishing a supplier having a bad batch from a supplier on the way out. Numbers rather than impressions, if you have them.
FDA_TrackerJim said:Prices dramatically below market are the strongest single signal, and the reason is arithmetic rather than suspicion.
That is correct as far as it goes, and here is where it stops going. The pattern that distinguishes a bad batch from an exit is behaviour rather than product. A bad batch comes with communication, a reshipment offer and a batch number. An exit comes with slower replies, pressure toward less reversible payment methods, sudden discounting, and the same reassurance repeated without any new information. The product tells you less than the correspondence does.
FDA_TrackerJim said:Prices dramatically below market are the strongest single signal, and the reason is arithmetic rather than suspicion.
I disagree that testing history is decisive. It tells you what a supplier did when they were being watched. Continuity of behaviour under stress — a late shipment, a failed test, a complaint — is more predictive than any run of good results.
Janoshik Analytical — Independent Testing
Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.
Verify Your PeptidesGL Biochem (Shanghai) Ltd. — Direct Manufacturer
Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.
Browse GL BiochemAnswering the narrow version, because the broad one does not have a single answer. The useful checklist is about verifiability rather than presentation. Independent test results commissioned by buyers rather than by the seller, consistency across multiple batches over time rather than one flattering report, a physical address and a company registration that resolve, batch and lot numbers on the actual labelling, and a shipping practice that matches what the material needs. Everything a good-looking website provides is cheap to fake; none of the items above are.
PurityPaulOR said:The pattern that distinguishes a bad batch from an exit is behaviour rather than product.
This matches mine closely enough to be worth saying so out loud.